2 Minute Medicine

No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract Higher risk of mortality during COVID-19 infection among patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib at COVID-19 diagnosis

byKathleen Lau

January 29, 2021

in StudyGraphics

RELATED REPORTS

Hematologic inflammatory indices may predict prognosis in younger patients with COVID-19 but not older patients

Younger age and systemic metastases may independently predict survival among patients with choroidal metastases

A digital mental health intervention may improve anxiety in breast cancer survivors

Tags: blood blood cancer cancer covid covid-19 diagnosis covid-19 infection discontinuation discontinue treatment essential thrombocythemia follow up hematology infection mortality mortality rate mortality risk multivariate analysis myelofibrosis myeloproliferative neoplasm neoplasm observational cohort study observational retrospective study oncology platelet polycythemia vera prefibrotic primary myelofibrosis rapid discontinuation rbc red blood cell retrospective retrospective study risk factor risk factors survival outcomes survivorship thrombocythemia univariate analysis viral virus wbc white blood cell white blood cell count withdrawal

Dihydroartemisinin-piperaquine reduces children death or readmission with severe anemia

2 Minute Medicine Rewind Jan 25, 2021

RelatedReports

Novel coronavirus identified from patients with pneumonia in Wuhan, China

Chronic Disease

Hematologic inflammatory indices may predict prognosis in younger patients with COVID-19 but not older patients

Adalimumab aids in control of noninfectious uveitis

Chronic Disease

Younger age and systemic metastases may independently predict survival among patients with choroidal metastases

Variability in interpretation of breast biopsy slides associated with low verification of atypia and ductal carcinoma in situ

Chronic Disease

A digital mental health intervention may improve anxiety in breast cancer survivors

Radiation plus hormone therapy may improve prostate cancer survival

Chronic Disease

Enzalutamide (Xtandi) and abiraterone (Zytiga) may have similar effectiveness in metastatic castration-sensitive prostate cancer

Next Post

Colchicine may lower the risk of cardiovascular events in patients with coronary disease

2 Minute Medicine Rewind Jan 25, 2021

Majority of obese tenth-graders already obese by fifth grade

Time restricted eating effective as a modest weight loss strategy for obese adults

Prescription of antibiotics for acute respiratory infections increasing

Tocilizumab not superior to standard care in randomized controlled trial for severe COVID-19 patients

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.